Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Cystic Fibrosis Ireland chief executive Sarah Tecklenborg says people can now “plan for the future with greater confidence” ...

Your health care provider may monitor how well your liver is working. How Was It Studied for the Treatment of Cystic Fibrosis? The effectiveness and safety of Alyftrek for cystic fibrosis was ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Liver fibrosis is the ...

Major discrepancies are seen with the use of noninvasive tests compared with liver biopsy in a posttransplant setting.

People with cystic fibrosis can develop endocrine, gastrointestinal, pancreatic, liver and reproductive disorders, but lung disease is often the most common complication and the principal cause of ...

While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

"Newborn screening for cystic fibrosis has been universal in the U.S. since 2010; however, there is significant variation ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...

Michael Welsh, University of Iowa physician and professor of internal medicine, has received the 2025 Canada Gairdner ...